Clinical Trial Update: Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating pharmacological therapy to modulate regional brain activation in schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of Jena | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED